John Bryant

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine · 2004 · 6.4K citations · Full text

Medicine, Oncology, Breast Oncology +12

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

Bernard Fisher, Stewart Anderson, John Bryant et al. · New England Journal of Medicine · 2002 · 6.2K citations · Full text

Medicine, Oncology, Surgery +13

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Soonmyung Paik, Gong Tang, Steven Shak et al. · Journal of Clinical Oncology · 2006 · 2.6K citations

Medicine, Cancer Biology, Oncology +17

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Bernard Fisher, John Bryant, Norman Wolmark et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Medicine, Oncology, Surgery +17